Genotoxicity of a freshwater cyanotoxin, cylindrospermopsin, in two human cell lines: Caco-2 and HepaRG

Environmental and Molecular Mutagenesis

Volumn 51, Issue 3, 2010, Pages 251-259

  Bazin, Emmanuelle ^a   Mourot, Annick ^a   Humpage, Andrew R ^b   Fessard, Valérie ^a  

^a Healthy Pigs Production and Experimentation Section   (France)

^b AUSTRALIAN WATER QUALITY CENTRE   (Australia)

Author keywords

Cytochrome P450; Ketoconazole; Micronucleus assay

Indexed keywords

CYANOTOXIN; CYLINDROSPERMOPSIN; CYTOCHROME P450; FRESH WATER; KETOCONAZOLE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; MUTAGENIC AGENT; URACIL;

ARTICLE; CELL STRAIN CACO 2; CELL STRAIN HEPARG; CELL TYPE; COLON; CONTROLLED STUDY; CYTOTOXICITY; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIVER; METABOLIC ACTIVATION; METABOLISM; MICRONUCLEUS; CELL LINE; MICRONUCLEUS TEST;

ANIMALIA; CYANOBACTERIA; MUS;

CACO-2 CELLS; CELL LINE; HUMANS; KETOCONAZOLE; MICRONUCLEUS TESTS; MUTAGENS; URACIL;

EID: 77950351190     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20539     Document Type: Article

References (46)

1. Baldwin S, Bloomer J, Smith G, Ayrton A, Clarke S, Chenery R. 1995. Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica 25:261-270.
2. Boulenc X, Bourrie M, Fabre I, Roque C, Joyeux H, Berger Y, Fabre G. 1992. Regulation of cytochrome P4501A1 gene expression in a human intestinal cell line, Caco-2. J Pharmacol Exp Ther 263: 1471-1478. (Pubitemid 23157232)
3. Bourke ATC, Hawes RB, Neilson A, Stallman ND. 1983. An outbreak of hepato-enteritis (the Palm Island mystery disease) possibly caused by algal intoxication. Toxicon 21(Suppl 3):45-48.
4. Brandon EFA, Bosch TM, Deenen MJ, Levink R, van der Wal E, van Meerveld JBM, Bijl M, Beijnen JH, Schellens JHM, Meijerman I. 2006. Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (Caco-2, LS180) cell lines. Toxicol Appl Pharmacol 211: 1-10. (Pubitemid 43152092)
5. Carmichael WW, Azevedo SM, An JS, Molica RJ, Jochimsen EM, Lau S, Rinehart KL, Shaw GR, Eaglesham GK. 2001. Human fatalities from cyanobacteria: Chemical and biological evidence for cyanotoxins. Environ Health Perspect 109:663-668.
6. Cerec V, Glaise D, Garnier D, Morosan S, Turlin B, Drenou B, Gripon P, Kremsdorf D, Guguen-Guillouzo C, Corlu A. 2007. Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology 45: 957-967. (Pubitemid 46631564)
7. Chiswell R, Smith M, Norris R, Eaglesham G, Shaw G, Seawright A, Moore M. 1997. The cyanobacterium, Cylindrospermopsis raciborskii, and its related toxin, cylindrospermopsin. Aust J Ecotox 3:7-23.
8. Crespi CL, Penman WP, Hu M. 1996. Development of Caco2 cells expressing high level of cDNA-derived cytochrome: P4503A4. Pharm Res 13:1635-1641. (Pubitemid 26426885)
9. Djelloul S, Forgue-Lafitte M-E, Hermelin B, Mareel M, Bruyneel E, Baldi A, Giordano A, Chastre E, Gespach C. 1997. Enterocyte differentiation is compatible with SV40 large T expression and loss of p53 function in human colonic Caco-2 cells: Status of the pRb1 and pRb2 tumor suppressor gene products. FEBS Lett 406: 234-242. (Pubitemid 27166302)
10. Ebert B, Seidel A, Lampen A. 2005. Induction of phase-1 metabolizing enzymes by oltipraz, flavone and indole-3-carbinol enhance the formation and transport of benzo [a] pyrene sulfate conjugates in intestinal Caco-2 cells. Toxicol Lett 158: 140-151. (Pubitemid 41019352)
11. Falconer IR, Humpage AR. 2001. Preliminary evidence for in vivo tumor initiation by oral administration of extracts of the blue-green alga Cylindrospermopsis raciborskii containing the toxin cylindrospermopsin. Environ Toxicol 16:192-195.
12. Falconer IR, Humpage AR. 2006. Cyanobacterial (blue-green algal) toxins in water supplies: Cylindrospermopsins. Environ Toxicol 21: 299-304.
13. Falconer IR, Hardy SJ, Humpage AR, Froscio SM, Tozer GJ, Hawkins PR. 1999. Hepatic and renal toxicity of the blue-green alga (cyanobacterium) Cylindrospermopsis raciborskii in male Swiss albino mice. Environ Toxicol 14:143-150. (Pubitemid 129721413)
14. Fenech M. 2000. The in vitro micronucleus technique. Mutat Res 455: 81-95.
15. Fessard V, Bernard C. 2003. Cell alterations but no DNA strand breaks induced in vitro by cylindrospermopsin in CHO K1 cells. Environ Toxicol 18:353-359. (Pubitemid 37258748)
16. Froscio SM, Humpage AR, Burcham PC, Falconer IR. 2003. Cylindrospermopsin-induced protein synthesis inhibition and its dissociation from acute toxicity in mouse hepatocytes. Environ Toxicol 18:243-251.
17. Froscio SM, Fanok S, Humpage AR. 2009. Cytotoxicity screening for the cyanobacterial toxin cylindrospermopsin. J Toxicol Environ Health 72:345-349.
18. Guengerich FP. 1995. Human cytochrome P450 enzymes. In: Ortiz de Montellano P, editor. Cytochrome P450: Structure, Mechanism, and Biochemistry. New York: Plenum. pp 473-535.
19. Guillouzo A, Corlu A, Aninat C, Glaise D, Morel F, Guguen-Guillouzo C. 2007. The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem Biol Interact 168:66-73. (Pubitemid 46659919)
20. Harada KI, Ohtani I, Iwamoto K, Suzuki M, Watanabe MF, Watanabe M, Terao K. 1994. Isolation of cylindrospermopsin from a cyanobacterium Umezakia natans and its screening method. Toxicon 32:73-84. (Pubitemid 24047963)
21. Hawkins PR, Runnegar MT, Jackson AR, Falconer IR. 1985. Severe hepatotoxicity caused by the tropical cyanobacterium (blue-green alga) Cylindrospermopsis raciborskii (Woloszynska) Seenaya and Subba Raju isolated from a domestic water supply reservoir. Appl Environ Microbiol 50:1292-1295.
22. Humpage AR, Fenech M, Thomas P, Falconer IR. 2000. Micronucleus induction and chromosome loss in transformed human white cells indicate clastogenic and aneugenic action of the cyanobacterial toxin, cylindrospermopsin. Mutat Res 472:155-161.
23. Humpage AR, Fontaine F, Froscio S, Burcham P, Falconer IR. 2005. Cylindrospermopsin genotoxicity and cytotoxicity: Role of cytochrome P-450 and oxidative stress. J Toxicol Environ Health A 68:739-753. (Pubitemid 40734187)
24. Jossé R, Aninat C, Glaise D, Dumont J, Fessard V, Morel F, Poul J, Guguen-Guillouzo C, Guillouzo A. 2008. Long-term functional stability of human heparg hepatocytes and use for chronic toxicity and genotoxicity studies. Drug Metab Dispos 36:1111-1118. (Pubitemid 351717469)
25. Ku WW, Bigger A, Brambilla G, Glatt H, Gocke E, Guzzie PJ, Hakura A, Honma M, Martus H-J, Obach RS, Roberts S. 2007. Strategy for genotoxicity testing - Metabolic considerations. Mutat Res 627:59-77 (Reports of the 4th International Workshop on Genotoxicity Testing (IWGT), September 9-10, 2005, San Francisco).
26. Lankoff A, Wojcik A, Lisowska H, Bialczyk J, Dziga D, Carmichael WW. 2007. No induction of structural chromosomal aberrations in cylindrospermopsin- treated CHO-K1 cells without and with metabolic activation. Toxicon 50:1105-1115. (Pubitemid 350087177)
27. Li R, Carmichael WW, Brittain S, Eaglesham GK, Shaw GR, Liu Y, Watanabe MK. 2001. First report of the cyanotoxins cylindrospermopsin and deoxycylindrospermopsin from Raphidiopsis curvata (Cyanobacteria). J Phycol 37:1121-1126. (Pubitemid 34067670)
28. Neumann C, Bain P, Shaw G. 2007. Studies of the comparative in vitro toxicology of the cyanobacterial metabolite deoxycylindrospermopsin. J Toxicol Environ Health A: Curr Issues 70:1679-1686. (Pubitemid 47347241)
29. Norris RLG, Seawright AA, Shaw GR, Senogles P, Eaglesham GK, Smith MJ, Chiswell RK, Moore MR. 2002. Hepatic xenobiotic metabolism of cylindrospermopsin in vivo in the mouse. Toxicon 40:471-476. (Pubitemid 34014819)
30. Obach R, Zhang Q, Dunbar D, Kaminsky L. 2001. Metabolic characterization of the major human small intestinal cytochrome P450s. Drug Metab Dispos 29:347-352. (Pubitemid 32179537)
31. Ohtani I, Moore RE, Runnegar MT. 1992. Cylindrospermopsin: A potent hepatotoxin from blue-green alga Cylindrospermopsis raciborskii. J Am Chem Soc 114:7941-7942.
32. Paine M, Schmiedlin-Ren P, Watkins P. 1999. Cytochrome P-450 1A1 expression in human small bowel: interindividual variation and inhibition by ketoconazole. Drug Metab Dispos 27: 360-364. (Pubitemid 29114243)
33. Pelkonen O, Turpeinen M, Hakkola J, Honkakoski P, Hukkanen J, Raunio H. 2008. Inhibition and induction of human cytochrome P450 enzymes: Current status. Arch Toxicol 82:667-715.
34. Pfrunder A, Gutmann H, Beglinger C, Drewe J. 2003. Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. J Pharm Pharmacol 55:59-66. (Pubitemid 36142082)
35. Preußel K, Stuken A, Wiedner C, Chorus I, Fastner J. 2006. First report on cylindrospermopsin producing Aphanizomenon flos-aquae (Cyanobacteria) isolated from two German lakes. Toxicon 47: 156-162. (Pubitemid 43143224)
36. Runnegar MT, Kong SM, Zhong YZ, Ge JL, Lu SC. 1994. The role of glutathione in the toxicity of a novel cyanobacterial alkaloid cylindrospermopsin in cultured rat hepatocytes. Biochem Biophys Res Commun 201:235-241.
37. Runnegar MT, Kong SM, Zhong YZ, Lu SC. 1995. Inhibition of reduced glutathione synthesis by cyanobacterial alkaloid cylindrospermopsin in cultured rat hepatocytes. Biochem Pharmacol 49:219-225.
38. Schembri MA, Neilan BA, Saint CP. 2001. Identification of genes implicated in toxin production in the cyanobacterium Cylindrospermopsis raciborskii. Environ Toxicol 16:413-421.
39. Seifert M, McGregor G, Eaglesham G, Wickramasinghe W, Shaw G. 2007. First evidence for the production of cylindrospermopsin and deoxy-cylindrospermopsin by the freshwater benthic cyanobacterium, Lyngbya wollei (Farlow ex Gomont) Speziale and Dyck. Harmful Algae 6:73-80. (Pubitemid 46038239)
40. Shaw GR, Sukenik A, Livne A, Chiswell RK, Smith MJ, Seawright AA, Norris RL, Eaglesham GK, Moore MR. 1999. Blooms of the cylindrospermopsin containing cyanobacterium, Aphanizomenon ovalisporum (Forti), in newly constructed lakes, Queensland, Australia. Environ Toxicol 14:167-177. (Pubitemid 129721417)
41. Shaw GR, Seawright AA, Moore MR, Lam PK. 2000. Cylindrospermopsin, a cyanobacterial alkaloid: Evaluation of its toxicologic activity. Ther Drug Monit 22:89-92.
42. Shen X, Lam PKS, Shaw GR, Wickramasinghe W. 2002. Genotoxicity investigation of a cyanobacterial toxin, cylindrospermopsin. Toxicon 40:1499-1501. (Pubitemid 35284051)
43. Soars M, Gelboin H, Krausz K, Riley R. 2003. A comparison of relative abundance, activity factor and inhibitory monoclonal antibody approaches in the characterization of human CYP enzymology. Br J Clin Pharmacol 55:175.
44. Spoof L, Berg KA, Rapala J, Lahti K, Lepistö L, Metcalf JS, Codd GA, Meriluoto J. 2006. First observation of cylindrospermopsin in Anabaena lapponica isolated from the boreal environment (Finland). Environ Toxicol 21:552-560. (Pubitemid 44788786)
45. Stresser DM, Broudy MI, Ho T, Cargill CE, Blanchard AP, Sharma R, Dandeneau AA, Goodwin JJ, Turner SD, Erve JCL, Patten CJ, Dehal SS, Crespi CL. 2004. Highly selective inhibition of human CYP3A in vitro by azamulin and evidence that inhibition is irreversible. Drug Metab Dispos 32:105-112. (Pubitemid 38112542)
46. Terao K, Ohmori S, Igarashi K, Ohtani I, Watanabe MF, Harada KI, Ito E, Watanabe M. 1994. Electron microscopic studies on experimental poisoning in mice induced by cylindrospermopsin isolated from blue-green alga Umezakia natans. Toxicon 32: 833-843. (Pubitemid 24193482)